| Stem Cells May Gradually Replace Antirejection Drugs For Kidney ...
ScienceDaily (Jan. 24, 2008) After a transplant surgery, anti-rejection drugs for the organ recipient are a must, but with prolonged use can have serious side effects, including infections, heart disease and cancer. A team led by Joshua Miller, MD, a researcher at Northwestern University's Feinberg School of Medicine, is working with Northwestern Memorial Hospital's department of organ transplantation to enroll qualifying subjects in a new research study that seeks to transplant stem cells from a kidney donor's bone marrow into the recipient, with the hope of gradually eliminating the need for anti-rejection drugs. If research proves successful, it would mean a dramatic change in the post-transplant quality of life for the transplant recipient. .
Trio's classical sound a life-changing experience
Despite all the impressive accolades, Strezeva knew she didn't want to hop onto the lonely touring circuit without the company of some friends. "I personally enjoy working and collaborating with people much more," Strezeva said. "Plus, it's a lot more fun traveling with friends than being with myself." Now, four years later, the Manhattan Piano Trio is one of the busiest new ensembles in all of America. Bahl has the group playing in smaller cities all over the country, to be followed by a two-week tour of South Africa this spring. Tonight's Ravinia program includes delightful oddities such as Shostakovich's Jazz Suite No. 1 (in its Ravinia debut) and Anton Arensky's Trio No. 1 in D Minor, Op. 32, an admitted favorite of Bahl's. Bryant Manning is a locally based free-lance writer.
|
